000			01980 a2200265 4500
008			041203s xx 000 0 eng
022			_a1522-3264;
050			_aAC1.S5
082			_a050
100			_aTimmerman, Luke,
245		0	_aPractical Geniuses of Technology--Methodical Man: Ken Mohler. _cLuke Timmerman.
260			_bThe Seattle Times, _c2004.
440			_aSIRS Enduring Issues 2005. _nArticle 73, _pScience, _x1522-3264;
500			_aArticles Contained in SIRS Enduring Issues 2005.
500			_aOriginally Published: Practical Geniuses of Technology--Methodical Man: Ken Mohler, May 5, 2004; pp. n.p..
520			_a"Ken Mohler grew up a doctor's son in the Kansas cow town of Abilene. He liked the idea of helping patients--except when doctors felt helpless, out of treatment options. He was more attracted to the can-do mentality of his grandfather, an entrepreneur, and finding ways to apply it to medicine. It took most of his life to do it, starting with years of study in immunology and then a low-level job in a pharmaceutical company, but he found a way. Mohler is one of the few scientists of his generation who has created a breakthrough drug that has enabled bedridden patients to return to their jobs, or play golf, without pain. Mohler, 48, did it at Immunex, one of Seattle's pioneering biotechnology companies, and now runs research and development at a startup, Trubion Pharmaceuticals in Seattle." (THE SEATTLE TIMES) This article examines the work of a scientist whose research led to the relief of pain and suffering for thousands of sufferers of inflammatory diseases such as rheumatoid arthritis.
599			_aRecords created from non-MARC resource.
650			_aEnbrel
650			_aInflammation
650			_aMedicine _xResearch
600			_aMohler, Ken
650			_aRheumatoid arthritis _xTreatment
710			_aProQuest Information and Learning Company _tSIRS Enduring Issues 2005, _pScience. _x1522-3264;
942			_c UKN
999			_c36855 _d36855